Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -62.37% vs 38.54% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 106.52% vs -8.61% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -32.55% vs 131.30% in Mar 2024
Compare Balance Sheet Results of Vilin Bio Med
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.95
43.18
-29.23
-67.69%
Share Warrants & Outstandings
Total Reserve
9.11
44.62
-35.51
-79.58%
Shareholder's Funds
23.06
87.80
-64.74
-73.74%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.09
-26.82
26.91
100.34%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
6.42
-6.42
-100.00%
Total Non-Current Liabilities
0.09
-20.40
20.49
100.44%
Current Liabilities
Trade Payables
1.39
0.48
0.91
189.58%
Other Current Liabilities
0.61
13.72
-13.11
-95.55%
Short Term Borrowings
2.57
70.22
-67.65
-96.34%
Short Term Provisions
0.00
7.02
-7.02
-100.00%
Total Current Liabilities
4.57
91.44
-86.87
-95.00%
Total Liabilities
27.73
158.84
-131.11
-82.54%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
9.39
157.12
-147.73
-94.02%
Less: Accumulated Depreciation
8.11
41.79
-33.68
-80.59%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1.28
115.33
-114.05
-98.89%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.57
0.00
1.57
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
5.06
0.71
4.35
612.68%
Other Non Current Assets
7.26
9.73
-2.47
-25.39%
Total Non-Current Assets
15.17
125.78
-110.61
-87.94%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.41
1.43
2.98
208.39%
Sundry Debtors
6.31
13.88
-7.57
-54.54%
Cash and Bank
0.06
8.74
-8.68
-99.31%
Other Current Assets
1.08
1.74
-0.66
-37.93%
Short Term Loans and Advances
0.70
7.28
-6.58
-90.38%
Total Current Assets
12.56
33.06
-20.50
-62.01%
Net Current Assets (Including Current Investments)
7.99
-58.38
66.37
113.69%
Total Current Assets Excluding Current Investments
12.56
33.06
-20.50
-62.01%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
27.73
158.84
-131.11
-82.54%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
2.57
70.22
-67.65
-96.34%
Book Value per share (adjusted)
16.53
-5.43
21.96
404.42%
Annual - Borrowings
Borrowings 2.57 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -62.37% vs 38.54% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 2.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 106.52% vs -8.61% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 12.56 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -32.55% vs 131.30% in Mar 2024






